Condition
Mild Autonomous Cortisol Secretion clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Mild Autonomous Cortisol Secretion clinical trials that are recruiting, in United States. By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Ketoconazole's effect on the daily cortisol rhythm in MACS
The study tests whether a single 400 mg dose of ketoconazole can modify the daily cortisol rhythm in adults with Mild Autonomous Cortisol Secretion (MACS) compared with healthy volunteers.
-
Low-dose (1 mg) osilodrostat for mild autonomous cortisol secretion
This trial will test whether taking 1 mg of osilodrostat daily is safe and can lower cortisol measures in adults with mild autonomous cortisol secretion.
Related topics
Quick answers
How many Mild Autonomous Cortisol Secretion clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.